CervoMed (CRVO) Competitors $10.00 +0.01 (+0.10%) Closing price 04:00 PM EasternExtended Trading$10.04 +0.04 (+0.35%) As of 06:46 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock CRVO vs. RCKT, FULC, ABEO, ALDX, ATXS, BNTC, ADCT, IMAB, ALT, and CTMXShould you be buying CervoMed stock or one of its competitors? The main competitors of CervoMed include Rocket Pharmaceuticals (RCKT), Fulcrum Therapeutics (FULC), Abeona Therapeutics (ABEO), Aldeyra Therapeutics (ALDX), Astria Therapeutics (ATXS), Benitec Biopharma (BNTC), ADC Therapeutics (ADCT), I-Mab (IMAB), Altimmune (ALT), and CytomX Therapeutics (CTMX). These companies are all part of the "pharmaceutical products" industry. CervoMed vs. Its Competitors Rocket Pharmaceuticals Fulcrum Therapeutics Abeona Therapeutics Aldeyra Therapeutics Astria Therapeutics Benitec Biopharma ADC Therapeutics I-Mab Altimmune CytomX Therapeutics Rocket Pharmaceuticals (NASDAQ:RCKT) and CervoMed (NASDAQ:CRVO) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their dividends, institutional ownership, media sentiment, earnings, analyst recommendations, risk, profitability and valuation. Do analysts recommend RCKT or CRVO? Rocket Pharmaceuticals currently has a consensus target price of $16.73, indicating a potential upside of 421.29%. CervoMed has a consensus target price of $19.29, indicating a potential upside of 92.86%. Given Rocket Pharmaceuticals' higher possible upside, equities research analysts plainly believe Rocket Pharmaceuticals is more favorable than CervoMed.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Rocket Pharmaceuticals 1 Sell rating(s) 8 Hold rating(s) 8 Buy rating(s) 0 Strong Buy rating(s) 2.41CervoMed 1 Sell rating(s) 1 Hold rating(s) 6 Buy rating(s) 1 Strong Buy rating(s) 2.78 Do insiders & institutionals have more ownership in RCKT or CRVO? 98.4% of Rocket Pharmaceuticals shares are owned by institutional investors. Comparatively, 25.2% of CervoMed shares are owned by institutional investors. 24.8% of Rocket Pharmaceuticals shares are owned by insiders. Comparatively, 35.4% of CervoMed shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth. Which has more risk & volatility, RCKT or CRVO? Rocket Pharmaceuticals has a beta of 0.62, meaning that its share price is 38% less volatile than the S&P 500. Comparatively, CervoMed has a beta of -0.72, meaning that its share price is 172% less volatile than the S&P 500. Is RCKT or CRVO more profitable? Rocket Pharmaceuticals has a net margin of 0.00% compared to CervoMed's net margin of -290.72%. CervoMed's return on equity of -59.15% beat Rocket Pharmaceuticals' return on equity.Company Net Margins Return on Equity Return on Assets Rocket PharmaceuticalsN/A -65.11% -55.99% CervoMed -290.72%-59.15%-53.64% Does the media refer more to RCKT or CRVO? In the previous week, Rocket Pharmaceuticals had 1 more articles in the media than CervoMed. MarketBeat recorded 8 mentions for Rocket Pharmaceuticals and 7 mentions for CervoMed. Rocket Pharmaceuticals' average media sentiment score of 1.43 beat CervoMed's score of 1.00 indicating that Rocket Pharmaceuticals is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Rocket Pharmaceuticals 7 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive CervoMed 4 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has preferable valuation & earnings, RCKT or CRVO? CervoMed has higher revenue and earnings than Rocket Pharmaceuticals. CervoMed is trading at a lower price-to-earnings ratio than Rocket Pharmaceuticals, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioRocket PharmaceuticalsN/AN/A-$258.75M-$2.51-1.28CervoMed$9.74M9.50-$16.29M-$2.61-3.83 SummaryRocket Pharmaceuticals beats CervoMed on 9 of the 16 factors compared between the two stocks. Get CervoMed News Delivered to You Automatically Sign up to receive the latest news and ratings for CRVO and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding CRVO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CRVO vs. The Competition Export to ExcelMetricCervoMedMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$92.50M$3.14B$5.81B$10.03BDividend YieldN/A2.27%6.67%4.54%P/E Ratio-3.8321.4875.7526.29Price / Sales9.50233.25449.5181.86Price / CashN/A44.1225.7029.20Price / Book2.2210.0511.506.43Net Income-$16.29M-$53.33M$3.28B$270.56M7 Day Performance-0.99%2.18%1.30%3.01%1 Month Performance1.52%11.91%11.25%9.74%1 Year Performance-37.42%14.14%59.54%26.68% CervoMed Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CRVOCervoMed3.6464 of 5 stars$10.00+0.1%$19.29+92.9%-30.4%$92.50M$9.74M-3.834News CoveragePositive NewsAnalyst ForecastRCKTRocket Pharmaceuticals4.8655 of 5 stars$3.28-2.1%$16.73+410.2%-82.4%$353.92MN/A-1.31240Positive NewsFULCFulcrum Therapeutics0.9073 of 5 stars$6.48-2.6%$7.57+16.8%-14.9%$350.51M$80M-5.31100News CoveragePositive NewsABEOAbeona Therapeutics4.3957 of 5 stars$6.83-0.7%$19.50+185.5%+20.7%$350.23M$3.50M9.7690ALDXAldeyra Therapeutics2.4064 of 5 stars$5.84-0.3%$9.50+62.7%-7.0%$349.79MN/A-6.8710Positive NewsATXSAstria Therapeutics2.6131 of 5 stars$6.18-5.4%$29.00+369.3%-33.2%$348.77MN/A-3.0730BNTCBenitec Biopharma1.7668 of 5 stars$13.24+1.6%$26.00+96.4%+53.4%$347.56M$80K-8.7720News CoveragePositive NewsADCTADC Therapeutics2.9887 of 5 stars$3.08-5.4%$7.75+152.0%+30.1%$345.37M$70.84M-1.96310News CoverageShort Interest ↓IMABI-Mab2.8358 of 5 stars$4.16-2.1%$7.00+68.3%+314.6%$339.71M$3.89M0.00380News CoveragePositive NewsAnalyst ForecastALTAltimmune2.876 of 5 stars$3.83+3.2%$17.40+354.3%-40.2%$338.02M$20K-3.2550CTMXCytomX Therapeutics4.2504 of 5 stars$2.04-0.5%$5.75+181.9%+81.7%$336.42M$138.10M3.64170Positive News Related Companies and Tools Related Companies RCKT Alternatives FULC Alternatives ABEO Alternatives ALDX Alternatives ATXS Alternatives BNTC Alternatives ADCT Alternatives IMAB Alternatives ALT Alternatives CTMX Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:CRVO) was last updated on 9/9/2025 by MarketBeat.com Staff From Our PartnersWhy Trump’s “Smart Dollar” could rewrite the rulesMUST SEE: Donald Trump's Radical Overhaul of the U.S. Dollar Congress just approved President Trump's lates...Stansberry Research | SponsoredBuffett, Gates and Bezos Dumping StocksThe world's wealthiest individuals are making huge moves with their money. Warren Buffett just liquidated b...Banyan Hill Publishing | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | Sponsored“Sell Nvidia before earnings”Eric Fry just went live with one of his most controversial calls yet: “Sell Nvidia.” While Wall Street has bee...InvestorPlace | Sponsored2013 Bitcoin miner reveals his trading system (free)While everyone else is gambling on meme coins or chasing the next "100x moonshot," our members are systematica...Crypto Swap Profits | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | SponsoredWhat's the Best Way to Lower RMD Taxes?Turning 73 triggers a key IRS rule: you must begin taking required minimum distributions (RMDs) from certain r...SmartAsset | SponsoredWashington prepares for warWhile the headlines obsess over overseas conflicts, Washington has been quietly preparing for something much b...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CervoMed Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share CervoMed With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CRVO Stock Alerts